Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition
- PMID: 29921206
- PMCID: PMC6340157
- DOI: 10.2174/1567201815666180619105419
Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition
Abstract
Background: Niosomes are surfactant-based vesicular nanosystems that proved their efficiency in transdermal delivery by overcoming skin inherent anatomic barrier; startum corneum. Central composite design is an efficient tool for developing and optimizing niosomal formulations using fewer experiments.
Objective: The objective of this study was to prepare niosomes as a transdermal delivery system of diacerein using film hydration technique, employing central composite design, for avoiding its oral gastrointestinal problems.
Methods: Three-level three-factor central composite design was employed for attaining optimal niosomes formulation with the desired characteristics. Three formulation variables were assessed: amount of salt in hydration medium (X1), lipid amount (X2) and number of surfactant parts (X3). DCNloaded niosomes were evaluated for entrapment efficiency percent (Y1), particle size (Y2), polydispersity index (Y3) and zeta potential (Y4). The suggested optimal niosomes were subjected to further characterization and utilized as a nucleus for developing elastic vesicles for comparative ex vivo and in vivo studies.
Results: The values of the independent variables (X1, X2 and X3) in the optimal niosomes formulation were 0 g, 150 mg and 5 parts, respectively. It showed entrapment efficiency percentage of 95.63%, particle size of 436.65 nm, polydispersity index of 0.47 and zeta potential of -38.80 mV. Results of ex vivo permeation and skin deposition studies showed enhanced skin permeation and retention capacity of the prepared vesicles than drug suspension.
Conclusion: Results revealed that a transdermal niosomal system was successfully prepared and evaluated using central composite design which will result in delivering diacerein efficiently, avoiding its oral problems.
Keywords: Diacerein; central composite; ex vivo permeation; niosomes; optimization; skin deposition studies..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Figures






Similar articles
-
Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study.J Liposome Res. 2019 Mar;29(1):73-85. doi: 10.1080/08982104.2018.1430831. Epub 2018 Feb 6. J Liposome Res. 2019. PMID: 29355060
-
Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation.Drug Deliv. 2018 Nov;25(1):815-826. doi: 10.1080/10717544.2018.1451572. Drug Deliv. 2018. PMID: 29557244 Free PMC article.
-
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.Biomed Pharmacother. 2017 Sep;93:255-266. doi: 10.1016/j.biopha.2017.06.043. Epub 2017 Jul 18. Biomed Pharmacother. 2017. PMID: 28738502
-
Quality by design for Niosome-Based nanocarriers to improve transdermal drug delivery from lab to industry.Int J Pharm. 2024 Dec 5;666:124747. doi: 10.1016/j.ijpharm.2024.124747. Epub 2024 Sep 24. Int J Pharm. 2024. PMID: 39326474 Review.
-
A comprehensive review on transethosomes as a novel vesicular approach for drug delivery through transdermal route.J Liposome Res. 2024 Mar;34(1):203-218. doi: 10.1080/08982104.2023.2221354. Epub 2023 Jun 20. J Liposome Res. 2024. PMID: 37338000 Review.
Cited by
-
Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study.Pharmaceutics. 2022 Aug 22;14(8):1746. doi: 10.3390/pharmaceutics14081746. Pharmaceutics. 2022. PMID: 36015372 Free PMC article.
-
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in vivo permeation analysis.Daru. 2025 Mar 29;33(1):17. doi: 10.1007/s40199-025-00560-3. Daru. 2025. PMID: 40156679
-
Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique.J Cancer Res Clin Oncol. 2023 Dec;149(20):18065-18080. doi: 10.1007/s00432-023-05482-8. Epub 2023 Nov 20. J Cancer Res Clin Oncol. 2023. PMID: 37982828 Free PMC article.
-
Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines.Pharmaceuticals (Basel). 2022 Mar 13;15(3):348. doi: 10.3390/ph15030348. Pharmaceuticals (Basel). 2022. PMID: 35337145 Free PMC article.
-
Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the Treatment of Androgenic Alopecia.Pharmaceutics. 2020 Sep 11;12(9):866. doi: 10.3390/pharmaceutics12090866. Pharmaceutics. 2020. PMID: 32933001 Free PMC article.
References
-
- Komiyama M., Yoshimoto K., Sisido M., Ariga K. Chemistry can make strict and fuzzy controls for bio-systems: DNA nanoarchitectonics and cell-macromolecular nanoarchitectonics. Bull. Chem. Soc. Jpn. 2017;90(9):967–1004.
-
- Kim C.J., Kurauchi S., Uebayashi T., Fujisaki A., Kimura S. Morphology change from nanotube to vesicle and monolayer/bilayer alteration by amphiphilic block polypeptides having aromatic groups at C terminal. Bull. Chem. Soc. Jpn. 2017;90(5):568–573.
-
- NVS, M. Saini, A. Niosomes. A novel drug delivery system. Int. J. Res. Pharm. Chem. 2011;1(3):498–511.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials